Impact of Bacillus Calmette-Guérin vaccination on Severe Combined Immunodeficiency infants in Brazil
DOI:
https://doi.org/10.11606/issn.2176-7262.rmrp.2026.234994Palabras clave:
Severe Combined Immunodeficiency; BCG Vaccine; Newborn Screening; Adverse Reactions; Attenuated Vaccines.Resumen
Purpose: Severe Combined Immunodeficiency (SCID) is an inborn error of immunity characterized by a profoundly impaired number or function of T lymphocytes. A frequent clinical presentation involves severe and widespread complications due to BCG (Bacillus Calmette-Guérin) vaccine. Considering
that very few data on SCID and BCG vaccination have been published in Brazil, we present a narrative review of complications and risks associated with BCG vaccination in Brazilian SCID patients. Methods: PubMed, Scopus, and Web of Science databases were assessed to identify papers on BCG-
associated complications in SCID patients from 2000 to 2024. Only studies involving humans were included. Results: A total of twelve studies were included, six of which were clinical trials evaluating complications associated with BCG vaccination in SCID patients. Notably, four of these trials were conducted in Brazil. Since the 1960s, BCG vaccine has been routinely administered at birth in several countries. In Brazil, BCG vaccine is part of the nationwide vaccination schedule and is given to all
children between birth and five years of age. Prevalence BCG vaccine-associated complications in SCID patients is estimated to be higher than in the general population. Rates of BCG complications as the first manifestation of SCID and deaths associated with the BCG vaccine are very high in Brazil.
Some strategies have been proposed to avoid these complications, such as implementing newborn screening for SCID, among others. Conclusion: Pediatricians must be aware that BCG vaccine-associated complications can be the first presentation of SCID and are highly frequent in SCID patients.
These complications should be regarded as warning signs for the diagnosis of SCID. Further multicenter studies focusing on the association between BCG vaccine-associated complications and
SCID in the Brazilian population are needed.
Descargas
Referencias
1. Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, Al-Herz W, et al. The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity. J Clin Immunol [Internet]. 2022;42(7):1508–20.
2. Fleisher TA. Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United States. Pediatrics. 2015;136(Suppl 3):S275–6.
3. Fleisher TA. Transplantation Outcomes for Severe Combined Immunodeficiency 2000–2009. Pediatrics. 2015;136(Suppl 3):S276–7.
4. Eldeniz FC, Gul Y, Yorulmaz A, Guner SN, Keles S, Reisli I. Evaluation of the 10 Warning Signs in Primary and Secondary Immunodeficient Patients. Front Immunol. 2022;13:1–9.
5. Lyra PT, Souza E, Moura ACA, Matta MC, Torres LC, Coelho AVC, et al. Inborn Errors of Immunity in Patients with Adverse Events Following BCG Vaccination in Brazil. J Clin Immunol. 2022;42(8):1708–20.
6. Marciano BE, Huang C-Y, Joshi G, Rezaei N, Costa-Carvalho B, Allwood Z, et al. BCG vaccination in SCID patients: complications, risks and vaccination policies. J Allergy Clin Immunol. 2014; 133 (4): 1134-1141.
7. Mazzucchelli JTL, Bonfim C, Castro GG, Condino-Neto AA, Costa NMX, Cunha L, et al. Severe combined immunodeficiency in Brazil: Management, prognosis, and BCG-associated complications. J Investig Allergol Clin Immunol. 2014;24(3):184–91.
8. Botaro MH, Maria e Silva J, Jamra SRA, Geraldino SZ, Roxo-Junior P. BCG vaccination in children with severe combined immunodeficiency in a tertiary center: evaluation of complications and risks. J Pediatr (Rio J) 2025; 101(2): 224-230.
9. Roxo-Junior P, Silva J, Andrea M, Oliveira L, Ramalho F, Bezerra T, et al. A family history of serious complications due to BCG vaccination is a tool for the early diagnosis of severe primary immunodeficiency. Ital J Pediatr. 2013;39(1):2–5.
10. Kobrynski LJ. Newborn Screening in the Diagnosis of Primary Immunodeficiency. Clin Rev Allergy Immunol [Internet]. 2022;63(1):9–21.
11. Zeng Y, Ying W, Wang W, Hou J, Liu L, Sun B, et al. Clinical and Genetic Characteristics of BCG Disease in Chinese Children: a Retrospective Study. J Clin Immunol. 2023;43(4):756–68.
12. Romanus V, Fasth A, Tordai P, Wiholm BE. Adverse reactions in healthy and immunocompromised children under six years of age vaccinated with the Danish BCG vaccine, strain Copenhagen 1331: implications for the vaccination policy in Sweden. Acta Paediatr. 1993;82(s385):1043–52.
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2026 Persio Roxo-Junior, Renata Gomes de Oliveira

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.



